Safety of Direct Oral Anticoagulants for Gastrointestinal Hemorrhage in Patients With Nonvalvular Atrial Fibrillation

Paraschos Archontakis‐Barakakis(Albert Einstein College of Medicine), George Ntaios(Çevre, Şehircilik ve İklim Değişikliği Bakanlığı), Spyros Peppas(Athens Naval & Veterans Hospital), Dimitriοs Schizas(Laiko General Hospital of Athens), Sanjana Nagraj(Jacobi Medical Center), Damianos G. Kokkinidis(Memorial Hospital of South Bend), Michail Kladas(New York City Health and Hospitals Corporation), Weijia Li(Jacobi Medical Center), Panagiotis Korantzopoulos(University of Ioannina)
Journal of Clinical Gastroenterology
November 15, 2022
10.1097/mcg.0000000000001796
Cited by 12

Related Papers

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York
|Metabolism|2020|901
Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity
|JAMA Cardiology|2019|418
Searching for Atrial Fibrillation Poststroke
|Circulation|2019|247
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation
|New England Journal of Medicine|2023|217
Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke
|European Heart Journal|2022|138